As has been shown, during PC progression, the cells favor the latter, providing the advantage of an alternative source of steroidal signaling activated to retract from the androgens; hence, these patients become an AR-negative subpopulation, proving the initial potential for an aggressive course of PC and constituting a stratification niche preceding progression into CRPC or even mCRPC [68]. Here, AR is linked to pachyonychia congenita.